{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:51:46Z","timestamp":1795150306896,"version":"4.10.3"},"reference-count":108,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18ek0109362h0001"],"award-info":[{"award-number":["18ek0109362h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00144"],"award-info":[{"award-number":["PI19\/00144"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["R01-AG AG031189"],"award-info":[{"award-number":["R01-AG AG031189"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["R01-AG062562"],"award-info":[{"award-number":["R01-AG062562"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["R56-AG055619"],"award-info":[{"award-number":["R56-AG055619"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013945","name":"Institut de Recherches Servier","doi-asserted-by":"publisher","award":["PCT\/EP2019\/070457"],"award-info":[{"award-number":["PCT\/EP2019\/070457"]}],"id":[{"id":"10.13039\/501100013945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019735","name":"MedDay Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1105784"],"award-info":[{"award-number":["APP1105784"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["14507303"],"award-info":[{"award-number":["14507303"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Neurology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/s1474-4422(20)30477-4","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:35:00Z","timestamp":1613608500000},"page":"235-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":331,"title":["Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease"],"prefix":"10.1016","volume":"20","author":[{"given":"Peter","family":"Hermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Appleby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Brandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Caughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Geschwind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Ha\u00efk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor G","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ladogana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc","family":"Llorens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Mead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvankar","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Parchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Pocchiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Zanusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S1474-4422(20)30477-4_bib1","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000160117.56690.B2","article-title":"Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada","volume":"64","author":"Ladogana","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(20)30477-4_bib2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib4","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(20)30477-4_bib5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1212\/WNL.58.2.192","article-title":"Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease","volume":"58","author":"Otto","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(20)30477-4_bib6","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/brain\/awl159","article-title":"Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease","volume":"129","author":"Collins","year":"2006","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(20)30477-4_bib7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archneur.60.6.813","article-title":"Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease","volume":"60","author":"Geschwind","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.2294","article-title":"Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion","volume":"17","author":"Atarashi","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/S1474-4422(20)30477-4_bib9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.23589","article-title":"RT-QuIC analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease","volume":"72","author":"McGuire","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib10","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1007\/s12035-015-9133-2","article-title":"Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease","volume":"53","author":"Cramm","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24833","article-title":"Diagnostic and prognostic value of human prion detection in cerebrospinal fluid","volume":"81","author":"Foutz","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib12","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1212\/WNL.0000000000005860","article-title":"Validation and utilisation of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance","volume":"91","author":"Hermann","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(20)30477-4_bib14","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00415-011-5960-x","article-title":"Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease","volume":"258","author":"Noguchi-Shinohara","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/srep38737","article-title":"Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease","volume":"6","author":"Steinacker","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/S1474-4422(20)30477-4_bib16","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/ene.13389","article-title":"Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort","volume":"24","author":"Kovacs","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jamaneurol.2016.4614","article-title":"Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples","volume":"74","author":"Bongianni","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bmj.309.6947.102","article-title":"Diagnostic tests 2: predictive values","volume":"309","author":"Altman","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/S1474-4422(20)30477-4_bib19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1750-3639.1995.tb00625.x","article-title":"Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases)","volume":"5","author":"Budka","year":"1995","journal-title":"Brain Pathol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/ana.21987","article-title":"Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease","volume":"67","author":"Heath","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib21","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1001\/jamaneurol.2016.3733","article-title":"Diagnosing sporadic Creutzfeldt-Jakob Disease by the detection of abnormal prion protein in patient urine","volume":"73","author":"Luk","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib22","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/35081095","article-title":"Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding","volume":"411","author":"Saborio","year":"2001","journal-title":"Nature"},{"key":"10.1016\/S1474-4422(20)30477-4_bib23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nmeth1066","article-title":"Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein","volume":"4","author":"Atarashi","year":"2007","journal-title":"Nat Methods"},{"key":"10.1016\/S1474-4422(20)30477-4_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cjp2.90","article-title":"Rapid amplification of prions from variant Creutzfeldt-Jakob disease cerebrospinal fluid","volume":"4","author":"Barria","year":"2018","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/S1474-4422(20)30477-4_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1257","article-title":"Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease","volume":"8","author":"Bougard","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/S1474-4422(20)30477-4_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6188","article-title":"Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease","volume":"8","author":"Concha-Marambio","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/S1474-4422(20)30477-4_bib27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJMoa1404401","article-title":"Prions in the urine of patients with variant Creutzfeldt-Jakob disease","volume":"371","author":"Moda","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(20)30477-4_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001217","article-title":"Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays","volume":"6","author":"Wilham","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/S1474-4422(20)30477-4_bib29","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/nprot.2016.120","article-title":"The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases","volume":"11","author":"Schmitz","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/S1474-4422(20)30477-4_bib30","article-title":"Bank vole prion protein as an apparently universal substrate for RT-QuIC-based detection and discrimination of prion strains","volume":"11","author":"Orr\u00fa","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/S1474-4422(20)30477-4_bib31","doi-asserted-by":"crossref","first-page":"e02451","DOI":"10.1128\/mBio.02451-14","article-title":"Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid","volume":"6","author":"Orr\u00fa","year":"2015","journal-title":"MBio"},{"key":"10.1016\/S1474-4422(20)30477-4_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMoa1315200","article-title":"A test for Creutzfeldt-Jakob disease using nasal brushings","volume":"371","author":"Orr\u00fa","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(20)30477-4_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/acn3.378","article-title":"Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis","volume":"4","author":"Groveman","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3988\/jcn.2016.12.1.101","article-title":"Real-time quaking-induced conversion analysis for the diagnosis of sporadic Creutzfeldt-Jakob disease in Korea","volume":"12","author":"Park","year":"2016","journal-title":"J Clin Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10922-w","article-title":"High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions","volume":"7","author":"Franceschini","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/S1474-4422(20)30477-4_bib36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00401-017-1683-0","article-title":"Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A\u03b242 levels","volume":"133","author":"Lattanzio","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/jnnp-2017-316853","article-title":"Imaging and CSF analyses effectively distinguish CJD from its mimics","volume":"89","author":"Rudge","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(20)30477-4_bib38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/19336896.2017.1345416","article-title":"An autopsy-verified case of steroid-responsive encephalopathy with convulsion and a false-positive result from the real-time quaking-induced conversion assay","volume":"11","author":"Hayashi","year":"2017","journal-title":"Prion"},{"key":"10.1016\/S1474-4422(20)30477-4_bib39","doi-asserted-by":"crossref","first-page":"e1017","DOI":"10.1212\/WNL.0000000000010086","article-title":"Diagnosis of prion diseases by RT-QuIC results in improved surveillance","volume":"95","author":"Rhoads","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(20)30477-4_bib40","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1007\/s00415-019-09537-0","article-title":"Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC","volume":"266","author":"Abu-Rumeileh","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneurol.2016.65","article-title":"Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease","volume":"12","author":"Zanusso","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib42","doi-asserted-by":"crossref","first-page":"E880","DOI":"10.3390\/ijms21030880","article-title":"High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD","volume":"21","author":"Fiorini","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S1474-4422(20)30477-4_bib43","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/acn3.51000","article-title":"Detection of prions in skin punch biopsies of Creutzfeldt-Jakob disease patients","volume":"7","author":"Mammana","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7785","article-title":"Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease","volume":"9","author":"Orr\u00fa","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/S1474-4422(20)30477-4_bib45","doi-asserted-by":"crossref","first-page":"e02095","DOI":"10.1128\/mBio.02095-18","article-title":"Prion seeds distribute throughout the eyes of sporadic Creutzfeldt-Jakob disease patients","volume":"9","author":"Orr\u00f9","year":"2018","journal-title":"MBio"},{"key":"10.1016\/S1474-4422(20)30477-4_bib46","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nrn1197","article-title":"14-3-3 proteins in the nervous system","volume":"4","author":"Berg","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/S1474-4422(20)30477-4_bib47","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1212\/WNL.0b013e31826d5fc3","article-title":"Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology","volume":"79","author":"Muayqil","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(20)30477-4_bib48","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","article-title":"CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease","volume":"67","author":"Sanchez-Juan","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(20)30477-4_bib49","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.0b013e318263565f","article-title":"A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease","volume":"79","author":"Hamlin","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(20)30477-4_bib50","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1093\/brain\/aws238","article-title":"Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years","volume":"135","author":"Stoeck","year":"2012","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(20)30477-4_bib51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jamaneurol.2014.4068","article-title":"Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease","volume":"72","author":"Dorey","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib52","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3233\/JAD-160740","article-title":"Diagnostic accuracy of a combined analysis of cerebrospinal fluid t-PrP, t-tau, p-tau, and A\u03b242 in the differential diagnosis of Creutzfeldt-Jakob disease from alzheimer's disease with emphasis on atypical disease variants","volume":"55","author":"Abu Rumeileh","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/S1474-4422(20)30477-4_bib53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13195-017-0331-1","article-title":"The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias","volume":"10","author":"Abu-Rumeileh","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/S1474-4422(20)30477-4_bib54","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuroscience.2016.02.057","article-title":"Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3\u03b3 assay","volume":"322","author":"Leit\u00e3o","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/S1474-4422(20)30477-4_bib55","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s12035-015-9167-5","article-title":"Validation of 14-3-3 protein as a marker in sporadic Creutzfeldt-Jakob disease diagnostic","volume":"53","author":"Schmitz","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/S1474-4422(20)30477-4_bib57","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1007\/s12035-016-0128-4","article-title":"Cerebrospinal fluid biomarkers in the diagnosis of Creutzfeldt-Jakob disease in slovak patients: over 10-year period review","volume":"54","author":"Koscova","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib58","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.neurobiolaging.2015.01.021","article-title":"Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease","volume":"36","author":"Karch","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1016\/S1474-4422(20)30477-4_bib59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/ane.12441","article-title":"CSF tau correlates with CJD disease severity and cognitive decline","volume":"133","author":"Cohen","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/S1474-4422(20)30477-4_bib60","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1471-2377-11-133","article-title":"Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study","volume":"11","author":"Coulthart","year":"2011","journal-title":"BMC Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib61","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cca.2019.04.081","article-title":"Diagnosis associated with Tau higher than 1200\u2008pg\/mL: insights from the clinical and laboratory practice","volume":"495","author":"Lehmann","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/S1474-4422(20)30477-4_bib62","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jocn.2018.01.064","article-title":"CSF Tau supplements 14-3-3 protein detection for sporadic Creutzfeldt-Jakob disease diagnosis while transitioning to next generation diagnostics","volume":"50","author":"Li","year":"2018","journal-title":"J Clin Neurosci"},{"key":"10.1016\/S1474-4422(20)30477-4_bib63","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000454802","article-title":"Cerebrospinal fluid biomarker-based diagnosis of sporadic Creutzfeldt-Jakob Disease: a validation study for previously established cutoffs","volume":"43","author":"Llorens","year":"2017","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/S1474-4422(20)30477-4_bib64","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/jamaneurol.2013.6455","article-title":"Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry","volume":"71","author":"Skillb\u00e4ck","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib65","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/alz.12133","article-title":"A prognostic model for overall survival in sporadic Creutzfeldt-Jakob disease","volume":"16","author":"Llorens","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/S1474-4422(20)30477-4_bib66","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jamaneurol.2019.1071","article-title":"Association of blood and cerebrospinal fluid Tau level and other biomarkers with survival time in sporadic Creutzfeldt-Jakob disease","volume":"76","author":"Staffaroni","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib67","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.mp.4001220","article-title":"Phospho-tau\/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias","volume":"8","author":"Riemenschneider","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/S1474-4422(20)30477-4_bib68","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jalz.2015.10.009","article-title":"Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia","volume":"12","author":"Llorens","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/S1474-4422(20)30477-4_bib69","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","article-title":"Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss","volume":"233","author":"Petzold","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/S1474-4422(20)30477-4_bib70","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jalz.2017.12.008","article-title":"Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: evaluation of diagnostic accuracy in the differential diagnosis of prion diseases","volume":"14","author":"Zerr","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/S1474-4422(20)30477-4_bib71","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jalz.2019.09.001","article-title":"Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias","volume":"16","author":"Antonell","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/S1474-4422(20)30477-4_bib72","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jocn.2018.09.031","article-title":"Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease","volume":"60","author":"Kanata","year":"2019","journal-title":"J Clin Neurosci"},{"key":"10.1016\/S1474-4422(20)30477-4_bib73","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/jnnp.2009.197962","article-title":"The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review","volume":"81","author":"Chohan","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(20)30477-4_bib74","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s12035-018-1251-1","article-title":"Cerebrospinal fluid total prion protein in the spectrum of prion diseases","volume":"56","author":"Villar-Piqu\u00e9","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib75","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1074\/mcp.RA119.001702","article-title":"Domain-specific quantification of prion protein in cerebrospinal fluid by targeted mass spectrometry","volume":"18","author":"Minikel","year":"2019","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/S1474-4422(20)30477-4_bib76","doi-asserted-by":"crossref","first-page":"7793","DOI":"10.1073\/pnas.1901947116","article-title":"Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development","volume":"116","author":"Vallabh","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1474-4422(20)30477-4_bib77","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jalz.2016.09.013","article-title":"Evaluation of \u03b1-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases","volume":"13","author":"Llorens","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.1016\/S1474-4422(20)30477-4_bib78","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s12035-017-0479-5","article-title":"Validation of \u03b1-synuclein as a CSF biomarker for sporadic Creutzfeldt-Jakob disease","volume":"55","author":"Llorens","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib79","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.dadm.2018.06.005","article-title":"Interlaboratory validation of cerebrospinal fluid \u03b1-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease","volume":"10","author":"Kruse","year":"2018","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/S1474-4422(20)30477-4_bib80","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/jnnp-2017-317793","article-title":"Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression","volume":"89","author":"Thompson","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(20)30477-4_bib81","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/1352458517715132","article-title":"Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod","volume":"24","author":"Piehl","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/S1474-4422(20)30477-4_bib82","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/jnnp-2020-323826","article-title":"Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease","volume":"91","author":"Abu-Rumeileh","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(20)30477-4_bib83","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/nan.12573","article-title":"Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases","volume":"46","author":"Llorens","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib84","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/WNL.0b013e31821a4439","article-title":"Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias","volume":"76","author":"Vitali","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(20)30477-4_bib85","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1055\/s-0037-1608808","article-title":"Neuroimaging in dementia","volume":"37","author":"Staffaroni","year":"2017","journal-title":"Semin Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib86","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1093\/brain\/awu298","article-title":"White matter involvement in sporadic Creutzfeldt-Jakob disease","volume":"137","author":"Caverzasi","year":"2014","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(20)30477-4_bib87","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00401-020-02168-0","article-title":"Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt-Jakob disease","volume":"140","author":"Pascuzzo","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib88","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1212\/CPJ.0000000000000111","article-title":"Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease","volume":"5","author":"Forner","year":"2015","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/S1474-4422(20)30477-4_bib89","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jamaneurol.2020.1319","article-title":"Evaluation of a new criterion for detecting prion disease with diffusion magnetic resonance imaging","volume":"77","author":"Bizzi","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib90","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2377-12-153","article-title":"MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease","volume":"12","author":"Carswell","year":"2012","journal-title":"BMC Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib91","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1007\/s00415-015-7723-6","article-title":"Diffusion-weighted MRI findings and clinical correlations in sporadic Creutzfeldt-Jakob disease","volume":"262","author":"Gao","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib92","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000445768","article-title":"The clinical stages of sporadic Creutzfeldt-Jakob disease with Met\/Met genotype in Korean patients","volume":"75","author":"Park","year":"2016","journal-title":"Eur Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib93","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jamaneurol.2015.3159","article-title":"Evolution of diffusion-weighted magnetic resonance imaging signal abnormality in sporadic Creutzfeldt-Jakob disease, with histopathological correlation","volume":"73","author":"Eisenmenger","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib94","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.24757","article-title":"Long-term preclinical magnetic resonance imaging alterations in sporadic Creutzfeldt-Jakob disease","volume":"80","author":"Zanusso","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib95","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/19336896.2017.1387348","article-title":"FDG-PET in Creutzfeldt-Jakob disease: analysis of clinical-PET correlation","volume":"11","author":"Renard","year":"2017","journal-title":"Prion"},{"key":"10.1016\/S1474-4422(20)30477-4_bib96","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.25300","article-title":"Sporadic fatal insomnia in europe: phenotypic features and diagnostic challenges","volume":"84","author":"Abu-Rumeileh","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib97","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/ana.20261","article-title":"Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease","volume":"56","author":"Steinhoff","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib98","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1212\/WNL.0b013e3181e39703","article-title":"Sporadic Creutzfeldt-Jakob disease mimicking nonconvulsive status epilepticus","volume":"74","author":"Lapergue","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(20)30477-4_bib99","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.seizure.2017.10.023","article-title":"Periodic EEG patterns in sporadic Creutzfeldt-Jakob-disease can be benzodiazepine-responsive and be difficult to distinguish from non-convulsive status epilepticus","volume":"53","author":"Marquetand","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/S1474-4422(20)30477-4_bib100","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.clinph.2017.01.019","article-title":"Redefining periodic patterns on electroencephalograms of patients with sporadic Creutzfeldt-Jakob disease","volume":"128","author":"Shin","year":"2017","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib101","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/jnnp-2016-313501","article-title":"Quantitative EEG parameters correlate with the progression of human prion diseases","volume":"87","author":"Franko","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(20)30477-4_bib102","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/B978-0-444-63945-5.00013-1","article-title":"Genetic Creutzfeldt-Jakob disease","volume":"153","author":"Ladogana","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib103","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3233\/JAD-160267","article-title":"Stratification by genetic and demographic characteristics improves diagnostic accuracy of cerebrospinal fluid biomarkers in rapidly progressive dementia","volume":"54","author":"Karch","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/S1474-4422(20)30477-4_bib104","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.24679","article-title":"Cerebrospinal fluid real-time quaking-induced conversion is a robust and reliable test for sporadic creutzfeldt-jakob disease: an international study","volume":"80","author":"McGuire","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib105","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-41694-0","article-title":"PMCA-replicated PrPD in urine of vCJD patients maintains infectivity and strain characteristics of brain PrPD: transmission study","volume":"9","author":"Cali","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/S1474-4422(20)30477-4_bib106","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/acn3.51057","article-title":"Transmission of CJD from nasal brushings but not spinal fluid or RT-QuIC product","volume":"7","author":"Raymond","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib107","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jclinepi.2016.03.022","article-title":"Partial verification bias and incorporation bias affected accuracy estimates of diagnostic studies for biomarkers that were part of an existing composite gold standard","volume":"78","author":"Karch","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S1474-4422(20)30477-4_bib108","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2807\/1560-7917.ES.2017.22.41.16-00715","article-title":"Accuracy of diagnosis criteria in patients with suspected diagnosis of sporadic Creutzfeldt-Jakob disease and detection of 14-3-3 protein, France, 1992 to 2009","volume":"22","author":"Peckeu","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/S1474-4422(20)30477-4_bib109","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12916-020-01608-8","article-title":"Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease","volume":"18","author":"Vallabh","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/S1474-4422(20)30477-4_bib110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(19)30403-X","article-title":"Towards a treatment for genetic prion disease: trials and biomarkers","volume":"19","author":"Vallabh","year":"2020","journal-title":"Lancet Neurol"}],"updated-by":[{"DOI":"10.1016\/s1474-4422(21)00069-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000}}],"container-title":["The Lancet Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442220304774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442220304774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T10:22:44Z","timestamp":1761474164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1474442220304774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1474442220304774"],"URL":"https:\/\/doi.org\/10.1016\/s1474-4422(20)30477-4","relation":{},"ISSN":["1474-4422"],"issn-type":[{"value":"1474-4422","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease","name":"articletitle","label":"Article Title"},{"value":"The Lancet Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1474-4422(20)30477-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}